Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 4
1954 5
1956 1
1957 3
1958 1
1959 3
1960 4
1961 3
1962 4
1963 8
1964 3
1965 5
1966 1
1967 4
1968 4
1969 5
1970 1
1971 3
1973 2
1974 2
1975 2
1976 6
1977 1
1978 2
1980 1
1982 1
1983 2
1984 3
1985 4
1986 4
1987 7
1988 7
1989 3
1990 3
1991 6
1993 3
1994 7
1995 4
1996 4
1997 4
1998 8
1999 4
2000 7
2001 11
2002 18
2003 19
2004 20
2005 18
2006 33
2007 36
2008 29
2009 47
2010 50
2011 47
2012 56
2013 69
2014 65
2015 81
2016 85
2017 95
2018 126
2019 116
2020 142
2021 161
2022 174
Text availability
Article attribute
Article type
Publication date

Search Results

1,484 results
Results by year
Filters applied: . Clear all
Page 1
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study.
Budde LE, Assouline S, Sehn LH, Schuster SJ, Yoon SS, Yoon DH, Matasar MJ, Bosch F, Kim WS, Nastoupil LJ, Flinn IW, Shadman M, Diefenbach C, O'Hear C, Huang H, Kwan A, Li CC, Piccione EC, Wei MC, Yin S, Bartlett NL. Budde LE, et al. Among authors: li cc. J Clin Oncol. 2022 Feb 10;40(5):481-491. doi: 10.1200/JCO.21.00931. Epub 2021 Dec 16. J Clin Oncol. 2022. PMID: 34914545 Clinical Trial.
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX; China Medical Treatment Expert Group for COVID-19. Guan WJ, et al. Among authors: li cc. Eur Respir J. 2020 May 14;55(5):2000547. doi: 10.1183/13993003.00547-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32217650 Free PMC article.
Current understanding of the mixed pain concept: a brief narrative review.
Freynhagen R, Parada HA, Calderon-Ospina CA, Chen J, Rakhmawati Emril D, Fernández-Villacorta FJ, Franco H, Ho KY, Lara-Solares A, Li CC, Mimenza Alvarado A, Nimmaanrat S, Dolma Santos M, Ciampi de Andrade D. Freynhagen R, et al. Among authors: li cc. Curr Med Res Opin. 2019 Jun;35(6):1011-1018. doi: 10.1080/03007995.2018.1552042. Epub 2019 Jan 3. Curr Med Res Opin. 2019. PMID: 30479161 Review.
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.
Budde LE, Sehn LH, Matasar M, Schuster SJ, Assouline S, Giri P, Kuruvilla J, Canales M, Dietrich S, Fay K, Ku M, Nastoupil L, Cheah CY, Wei MC, Yin S, Li CC, Huang H, Kwan A, Penuel E, Bartlett NL. Budde LE, et al. Among authors: li cc. Lancet Oncol. 2022 Aug;23(8):1055-1065. doi: 10.1016/S1470-2045(22)00335-7. Epub 2022 Jul 5. Lancet Oncol. 2022. PMID: 35803286 Clinical Trial.
Asymmetric Total Synthesis of Taxol.
Hu YJ, Gu CC, Wang XF, Min L, Li CC. Hu YJ, et al. Among authors: li cc. J Am Chem Soc. 2021 Oct 27;143(42):17862-17870. doi: 10.1021/jacs.1c09637. Epub 2021 Oct 12. J Am Chem Soc. 2021. PMID: 34641680
1,484 results